An international research group led by the Centenary Institute has developed a world first genetic…
View More Researchers develop genetic risk score to predict development of alcohol-induced cirrhosis
Home »
Exforge HCT
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EXFORGE® HCT…
View More Exforge HCT
Gender gap seen in accessing alcohol treatment with cirrhosis
(HealthDay)—Women with alcohol-associated cirrhosis (AC) are less likely to receive alcohol use disorder (AUD) treatment…
View More Gender gap seen in accessing alcohol treatment with cirrhosis